STERIS Plc (Ireland) (STE)
224.59
-2.24
(-0.99%)
USD |
NYSE |
Sep 04, 16:00
224.63
+0.04
(+0.02%)
After-Hours: 20:00
STERIS Research and Development Expense (Quarterly) : 28.60M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.60M |
| March 31, 2026 | 28.80M |
| December 31, 2025 | 29.50M |
| September 30, 2025 | 28.20M |
| June 30, 2025 | 26.40M |
| March 31, 2025 | 27.69M |
| December 31, 2024 | 27.36M |
| September 30, 2024 | 27.03M |
| June 30, 2024 | 25.57M |
| March 31, 2024 | 27.46M |
| December 31, 2023 | 25.26M |
| September 30, 2023 | 26.27M |
| June 30, 2023 | 24.69M |
| March 31, 2023 | 25.51M |
| December 31, 2022 | 25.51M |
| September 30, 2022 | 24.93M |
| June 30, 2022 | 24.75M |
| March 31, 2022 | 26.10M |
| December 31, 2021 | 24.82M |
| September 30, 2021 | 18.83M |
| June 30, 2021 | 18.19M |
| March 31, 2021 | 17.51M |
| December 31, 2020 | 16.44M |
| September 30, 2020 | 16.14M |
| June 30, 2020 | 16.23M |
| Date | Value |
|---|---|
| March 31, 2020 | 17.22M |
| December 31, 2019 | 16.49M |
| September 30, 2019 | 16.25M |
| June 30, 2019 | 15.58M |
| March 31, 2019 | 15.88M |
| December 31, 2018 | 15.17M |
| September 30, 2018 | 15.77M |
| June 30, 2018 | 16.22M |
| March 31, 2018 | 17.61M |
| December 31, 2017 | 15.20M |
| September 30, 2017 | 13.97M |
| June 30, 2017 | 14.00M |
| March 31, 2017 | 15.76M |
| December 31, 2016 | 14.59M |
| September 30, 2016 | 14.62M |
| June 30, 2016 | 14.43M |
| March 31, 2016 | 14.31M |
| December 31, 2015 | 14.33M |
| September 30, 2015 | 14.26M |
| June 30, 2015 | 13.76M |
| March 31, 2015 | 14.18M |
| December 31, 2014 | 14.55M |
| September 30, 2014 | 13.01M |
| June 30, 2014 | 12.41M |
| March 31, 2014 | 11.68M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Medtronic Plc | 771.00M |
| CVRx, Inc. | 3.13M |
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |